Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan-Reference-Cited by-同舟云学术

Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan

Published:2018-05-10 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chang Yi-Sheng,Lee Wan-Ju,Lim Chen-Chee,Wang Shih-Hao,Hsu Sheng-Min,Chen Yi-Chian,Cheng Chia-Yi,Teng Yu-Ti,Huang Yi-Hsun,Lai Chun-Chieh,Tseng Sung-Huei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-25864-0.pdf

Reference42 articles.

1. Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N Engl J Med. 358, 2606–2617 (2008).

2. Sobrin, L. & Seddon, J. M. Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res. 40, 1–15 (2014).

3. Huang, E. J. et al. Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study. Eye (Lond). 28, 705–714 (2014).

4. Hsu, W. C. & Hsu, Y. P. Patterns of outpatient care utilization by seniors under the National Health Insurance in Taiwan. J Formos Med Assoc. 115, 325–334 (2016).

5. Devenyi, R. et al. Real-world utilization of ranibizumab in wet age-related macular degeneration patients from Canada. Can J Ophthalmol. 51, 55–57 (2016).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal ranibizumab injection is associated with an increased risk of chronic kidney disease: a population-based study in Taiwan;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-28

2. Baseline characteristics and treatment response predictive of nAMD outcomes with ranibizumab therapy in treatment-naive patients: the RACER subgroup analysis;BMC Ophthalmology;2023-01-27

3. Ranibizumab reimbursement and treatment patterns for neovascular age-related macular degeneration in Taiwan – Results from the 12-month, observational RENOWNED study;Journal of the Formosan Medical Association;2022-10

4. Risk of dialysis in patients receiving intravitreal anti–vascular endothelial growth factor treatment: a population-based cohort study;Aging;2022-06-20

5. A 12-month, prospective, observational study of ranibizumab in treatment-naïve Taiwanese patients with neovascular age-related macular degeneration: the RACER study;BMC Ophthalmology;2020-11-25